FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306173812> ?p ?o ?g. }

• W4306173812 endingPage "106514" @default.
• W4306173812 startingPage "106514" @default.
• W4306173812 abstract "Multiple drug resistance (MDR) is the major obstacle for both chemotherapy and molecular-targeted therapy for cancer, which is mainly caused by overexpression of ABC transporters or genetic mutation of drug targets. Based on previous studies, we hypothesized that ROS/Nrf2 is the common target for overcoming acquired drug resistance to both targeted therapy and chemotherapy treatments. In this study, we firstly proved that the levels of ROS and Nrf2 were remarkably up-regulated in both H1975 (Gefitinib-resistant lung cancer cells with T790M) and A549/T (paclitaxel-resistant) cells, which is consistent with the clinical database analysis results of lung cancer patients that Nrf2 expression level is negatively related to survival rate. Nrf2 Knockdown with siRNA or tangeretin (TG, a flavonoid isolated from citrus peels) inhibited the MDR cell growth by suppressing the Nrf2 pathway, and efficiently enhanced the anti-tumor effects of paclitaxel and AZD9291 (the third generation of TKI) in A549/T or H1975, respectively. Moreover, TG sensitized A549/T cells-derived xenografts to paclitaxel via inhibiting Nrf2 and its downstream target P-gp, leading to an increased paclitaxel concentration in tumors. Collectively, targeting Nrf2 to enhance ROS may be a common target for overcoming the acquired drug resistance and enhancing the therapeutic effects of chemotherapy and molecular-targeted therapy." @default.
• W4306173812 created "2022-10-14" @default.
• W4306173812 creator A5013120307 @default.
• W4306173812 creator A5018785079 @default.
• W4306173812 creator A5037785133 @default.
• W4306173812 creator A5047044100 @default.
• W4306173812 creator A5054075262 @default.
• W4306173812 creator A5066590728 @default.
• W4306173812 creator A5082605046 @default.
• W4306173812 creator A5089957671 @default.
• W4306173812 date "2022-12-01" @default.
• W4306173812 modified "2023-10-14" @default.
• W4306173812 title "Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer" @default.
• W4306173812 cites W1785455093 @default.
• W4306173812 cites W1966882041 @default.
• W4306173812 cites W1968619160 @default.
• W4306173812 cites W1973070600 @default.
• W4306173812 cites W1992845564 @default.
• W4306173812 cites W1994604625 @default.
• W4306173812 cites W2012431429 @default.
• W4306173812 cites W2042619042 @default.
• W4306173812 cites W2068878269 @default.
• W4306173812 cites W2104807853 @default.
• W4306173812 cites W2108417479 @default.
• W4306173812 cites W2127286396 @default.
• W4306173812 cites W2164573650 @default.
• W4306173812 cites W2172716470 @default.
• W4306173812 cites W2282390010 @default.
• W4306173812 cites W2338371084 @default.
• W4306173812 cites W2339922740 @default.
• W4306173812 cites W2397751594 @default.
• W4306173812 cites W2408891447 @default.
• W4306173812 cites W2546719732 @default.
• W4306173812 cites W2552678153 @default.
• W4306173812 cites W2613045338 @default.
• W4306173812 cites W2759917944 @default.
• W4306173812 cites W2767950945 @default.
• W4306173812 cites W2769426045 @default.
• W4306173812 cites W2770024088 @default.
• W4306173812 cites W2792821195 @default.
• W4306173812 cites W2793873799 @default.
• W4306173812 cites W2803650576 @default.
• W4306173812 cites W2806892533 @default.
• W4306173812 cites W2901265038 @default.
• W4306173812 cites W2913469816 @default.
• W4306173812 cites W2957289901 @default.
• W4306173812 cites W2964317950 @default.
• W4306173812 cites W2990901194 @default.
• W4306173812 cites W3198212834 @default.
• W4306173812 cites W3214086311 @default.
• W4306173812 cites W950232622 @default.
• W4306173812 doi "https://doi.org/10.1016/j.phrs.2022.106514" @default.
• W4306173812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36252771" @default.
• W4306173812 hasPublicationYear "2022" @default.
• W4306173812 type Work @default.
• W4306173812 citedByCount "4" @default.
• W4306173812 countsByYear W43061738122022 @default.
• W4306173812 countsByYear W43061738122023 @default.
• W4306173812 crossrefType "journal-article" @default.
• W4306173812 hasAuthorship W4306173812A5013120307 @default.
• W4306173812 hasAuthorship W4306173812A5018785079 @default.
• W4306173812 hasAuthorship W4306173812A5037785133 @default.
• W4306173812 hasAuthorship W4306173812A5047044100 @default.
• W4306173812 hasAuthorship W4306173812A5054075262 @default.
• W4306173812 hasAuthorship W4306173812A5066590728 @default.
• W4306173812 hasAuthorship W4306173812A5082605046 @default.
• W4306173812 hasAuthorship W4306173812A5089957671 @default.
• W4306173812 hasConcept C114851261 @default.
• W4306173812 hasConcept C121608353 @default.
• W4306173812 hasConcept C126322002 @default.
• W4306173812 hasConcept C133936738 @default.
• W4306173812 hasConcept C143998085 @default.
• W4306173812 hasConcept C170493617 @default.
• W4306173812 hasConcept C2776256026 @default.
• W4306173812 hasConcept C2776694085 @default.
• W4306173812 hasConcept C2777292972 @default.
• W4306173812 hasConcept C2777930144 @default.
• W4306173812 hasConcept C2779438470 @default.
• W4306173812 hasConcept C2780035454 @default.
• W4306173812 hasConcept C2780580887 @default.
• W4306173812 hasConcept C42362537 @default.
• W4306173812 hasConcept C502942594 @default.
• W4306173812 hasConcept C71924100 @default.
• W4306173812 hasConcept C81729549 @default.
• W4306173812 hasConcept C86803240 @default.
• W4306173812 hasConcept C89423630 @default.
• W4306173812 hasConcept C98274493 @default.
• W4306173812 hasConceptScore W4306173812C114851261 @default.
• W4306173812 hasConceptScore W4306173812C121608353 @default.
• W4306173812 hasConceptScore W4306173812C126322002 @default.
• W4306173812 hasConceptScore W4306173812C133936738 @default.
• W4306173812 hasConceptScore W4306173812C143998085 @default.
• W4306173812 hasConceptScore W4306173812C170493617 @default.
• W4306173812 hasConceptScore W4306173812C2776256026 @default.
• W4306173812 hasConceptScore W4306173812C2776694085 @default.
• W4306173812 hasConceptScore W4306173812C2777292972 @default.
• W4306173812 hasConceptScore W4306173812C2777930144 @default.
• W4306173812 hasConceptScore W4306173812C2779438470 @default.

• next